-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EeWkQemjt4XFiK4EgGhGhozeJpENDKIvyOPc7ylLqviySQnspr18VTBLt1eE4Ay5 Q8WaqN7+5Q32DRbPb9wcNg== 0000899681-98-000259.txt : 19980424 0000899681-98-000259.hdr.sgml : 19980424 ACCESSION NUMBER: 0000899681-98-000259 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980422 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CAMBRIDGE NEUROSCIENCE INC CENTRAL INDEX KEY: 0000874384 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133319074 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-41681 FILM NUMBER: 98598526 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQ BUILD 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172250600 MAIL ADDRESS: STREET 1: ONE KENDALL SQ STREET 2: BLDG 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: CAMBRIDGE NEUROSCIENCE RESEARCH INC DATE OF NAME CHANGE: 19600201 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WARBURG PINCUS CAPITAL PARTNERS LIQUIDATING TRUST CENTRAL INDEX KEY: 0001049322 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 137130441 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: C/O EM WARBURG PINCUS & CO LLC STREET 2: 466 LEXINGTON AVENUE 10TH FL CITY: NEW YORK STATE: NY ZIP: 10017-3147 BUSINESS PHONE: 2128780600 MAIL ADDRESS: STREET 1: C/O EM WARBURG PINCUS & CO LLC STREET 2: 466 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 SC 13G/A 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* CAMBRIDGE NEUROSCIENCE, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 13242610 (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of Pages SCHEDULE 13G - ----------------------------------------------------------------------------- CUSIP No. 13242610 Page OF PAGES - ----------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Warburg, Pincus Capital Partners Liquidating Trust - ---------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) (b) X - ---------------------------------------------------------------------------- 3 SEC USE ONLY - ---------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION New York - ---------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES 0 - ---------------------------------------------------------------------------- BENEFICIALLY 6 SHARED VOTING POWER OWNED BY 0 - ---------------------------------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING 0 - ---------------------------------------------------------------------------- PERSON 8 SHARED DISPOSITIVE POWER WITH 0 - ---------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 - ---------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - ---------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0 - ---------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* OO - ---------------------------------------------------------------------------- * SEE INSTRUCTIONS BEFORE FILING OUT! ITEM 1(A). NAME OF ISSUER: Cambridge NeuroScience, Inc. ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: One Kendall Square Building 700 Cambridge, MA 02139 Items 2(a), (B) AND (C). NAME OF PERSON FILING; ADDRESS OF PRINCIPAL BUSINESS OFFICE; CITIZENSHIP: This statement is being filed by Warburg, Pincus Capital Partners Liquidating Trust (the "Trust"), whose business address is 466 Lexington Avenue, New York, New York 10017. ITEM 2(D). TITLE OF CLASS OF SECURITIES: Common Stock ITEM 2(E). CUSIP NUMBER: 13242610 ITEM 3. Not Applicable ITEM 4. OWNERSHIP: (a) 0 (b) 0 (c) (i) 0 (ii) 0 (iii) 0 (iv) 0 ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: At the date hereof, the Trust has ceased to be the beneficial owner of more than 5% of the Common Stock. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Not Applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Not Applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: Not Applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP: Not Applicable ITEM 10. CERTIFICATION: Not Applicable SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. WARBURG, PINCUS CAPITAL PARTNERS LIQUIDATING TRUST By:/s/ Stephen Distler Stephen Distler, Trustee Dated: April 21, 1998 -----END PRIVACY-ENHANCED MESSAGE-----